Accrued Income Taxes, Noncurrent in USD of RVL Pharmaceuticals plc from Q4 2017 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.
Summary
RVL Pharmaceuticals plc quarterly Accrued Income Taxes, Noncurrent history and change rate from Q4 2017 to Q1 2023.
  • RVL Pharmaceuticals plc Accrued Income Taxes, Noncurrent for the quarter ending 31 Mar 2023 was $71K, a 5.97% increase year-over-year.
Accrued Income Taxes, Noncurrent, Quarterly (USD)
Accrued Income Taxes, Noncurrent, YoY Quarterly Change (%)

RVL Pharmaceuticals plc Quarterly Accrued Income Taxes, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2023 $71K +$4K +5.97% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $70K +$4K +6.06% 31 Dec 2022 10-Q 14 Aug 2023
Q3 2022 $70K +$69K +6900% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $68K +$67K +6700% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $67K +$66K +6600% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $66K 31 Dec 2021 10-K 20 Mar 2023
Q3 2021 $1K 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 $1K 30 Jun 2021 10-Q 16 Aug 2021
Q1 2021 $1K 31 Mar 2021 10-Q 13 May 2021
Q3 2019 $2.48M +$412K +19.9% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $2.54M 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 $2.54M 31 Mar 2019 10-Q 12 May 2020
Q4 2018 $2.54M +$212K +9.11% 31 Dec 2018 10-K 19 Mar 2020
Q3 2018 $2.07M 30 Sep 2018 10-Q 14 Nov 2019
Q4 2017 $2.33M 31 Dec 2017 8-K 20 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.